Improving Lives Through Research
St. Charles Clinical Research is an independently owned company with over 40 years of combined experience in clinical trials. Our Friendly staff and personal approach provide the attention and professionalism crucial for the best patient experience.
Available Studies
We are now accepting volunteers for the following Clinical Research Studies:
C-Diff 1st Diagnosis or 1st Recurrence Treatment Study
Have you been diagnosed with C. difficile diarrhea? You may qualify if you are 18 years of age or older and have a first or second episode of C-diff infection (CDI.)
Study participants will be provided study medications, laboratory analyses, and follow up visits with our providers at no cost. A small stipend and help with transportation to and from the clinical research site may also be available.
C. Diff Treatment For Adults with Recurrent Infections
In a recent study, participants with recurrent C. diff who received CP101 after completing a round of antibiotics were significantly less likely to experience another episode of C. diff, compared to participants who received antibiotics alone. In the study, 74.5% of participants who received CP101 achieved a clinical cure, meaning they did not experience a recurrence of C. diff within 8 weeks of taking CP101.
CP101 is a microbiome therapy. The microbiome is the community of organisms that live in the intestinal tract.
More Studies Coming Soon
Screening for Colon Cancer
IBS-C
Click below to get notifed when new studies become available.
St. Charles Clinical Research
6034 Weldon Spring Parkway
Weldon Spring, Mo. 63304
General Inquiries
Pharmaceutical Study Experience
Abbott
Pfizer
SKK
SERES
Boston Scientific
Allergan
Merck
Biohaven
Techfield
Baxter
Furiex
Salix Pharmaceuticals
Covance
Cubist
Eli Lilly
GlaxoSmithKline
Galen
Iroko
Ironwood
Medicago
Medimmune
Novartis
Novavax
Noven Therapeutics
Seqirus USA
Teva USA
Vanda pharmaceuticals